9-134818991-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000093.5(COL5A1):​c.4393-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0317 in 1,613,360 control chromosomes in the GnomAD database, including 978 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 55 hom., cov: 32)
Exomes 𝑓: 0.032 ( 923 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2
Splicing: ADA: 0.00003457
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.0780

Publications

7 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 9-134818991-C-T is Benign according to our data. Variant chr9-134818991-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136897.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0249 (3790/152302) while in subpopulation NFE AF = 0.0331 (2248/68002). AF 95% confidence interval is 0.0319. There are 55 homozygotes in GnomAd4. There are 1887 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3790 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.4393-9C>T intron_variant Intron 56 of 65 ENST00000371817.8 NP_000084.3
COL5A1NM_001278074.1 linkc.4393-9C>T intron_variant Intron 56 of 65 NP_001265003.1
COL5A1XM_017014266.3 linkc.4393-9C>T intron_variant Intron 56 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.4393-9C>T intron_variant Intron 56 of 65 1 NM_000093.5 ENSP00000360882.3
COL5A1ENST00000371820.4 linkc.4393-9C>T intron_variant Intron 56 of 65 2 ENSP00000360885.4

Frequencies

GnomAD3 genomes
AF:
0.0249
AC:
3793
AN:
152186
Hom.:
55
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00685
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0266
Gnomad ASJ
AF:
0.0769
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.0445
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0331
Gnomad OTH
AF:
0.0349
GnomAD2 exomes
AF:
0.0265
AC:
6661
AN:
251182
AF XY:
0.0262
show subpopulations
Gnomad AFR exome
AF:
0.00653
Gnomad AMR exome
AF:
0.0218
Gnomad ASJ exome
AF:
0.0738
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0394
Gnomad NFE exome
AF:
0.0343
Gnomad OTH exome
AF:
0.0310
GnomAD4 exome
AF:
0.0324
AC:
47345
AN:
1461058
Hom.:
923
Cov.:
34
AF XY:
0.0316
AC XY:
22963
AN XY:
726860
show subpopulations
African (AFR)
AF:
0.00466
AC:
156
AN:
33480
American (AMR)
AF:
0.0224
AC:
1000
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0763
AC:
1995
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00451
AC:
389
AN:
86256
European-Finnish (FIN)
AF:
0.0356
AC:
1879
AN:
52716
Middle Eastern (MID)
AF:
0.0127
AC:
73
AN:
5768
European-Non Finnish (NFE)
AF:
0.0360
AC:
39994
AN:
1111900
Other (OTH)
AF:
0.0308
AC:
1858
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2426
4852
7278
9704
12130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1516
3032
4548
6064
7580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0249
AC:
3790
AN:
152302
Hom.:
55
Cov.:
32
AF XY:
0.0253
AC XY:
1887
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00683
AC:
284
AN:
41576
American (AMR)
AF:
0.0266
AC:
407
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0769
AC:
267
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00580
AC:
28
AN:
4826
European-Finnish (FIN)
AF:
0.0445
AC:
472
AN:
10618
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0331
AC:
2248
AN:
68002
Other (OTH)
AF:
0.0341
AC:
72
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
187
374
562
749
936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0272
Hom.:
33
Bravo
AF:
0.0242
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0351
EpiControl
AF:
0.0340

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 28, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1;BP6 -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 27, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:2
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome type 7A Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Jul 16, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Benign
0.91
PhyloP100
-0.078
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000035
dbscSNV1_RF
Benign
0.16
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11792181; hg19: chr9-137710837; API